Catherine Novack

Stock Analyst at Jones Trading

(0.69)
# 2546
Out of 5,441 analysts
26
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
DYN Dyne Therapeutics
Initiates Coverage On: Buy
30
11.23 167.14% 1 Jun 26, 2025
CAPR Capricor Therapeutic...
Maintains: Buy
40 29
7.82 270.84% 2 Jun 25, 2025
FEMY Femasys
Maintains: Buy
10 6
0.78 669.23% 2 May 13, 2025
RGLS Regulus Therapeutics
Downgrades: Hold
8 7
8.16 -14.22% 2 Apr 30, 2025
RLYB Rallybio
Downgrades: Hold
n/a
n/a n/a 1 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
41.54 8.33% 1 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
1.89 482.01% 1 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
130
14.99 767.24% 1 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 16
8.11 97.29% 2 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
3.79 269.39% 1 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 13
1.97 559.9% 2 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
5.93 68.63% 1 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
2.81 682.92% 1 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
n/a n/a 1 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
n/a n/a 1 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
4.91 409.16% 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
14.7 206.12% 1 Oct 4, 2021